Wilmington Savings Fund Society’s Krystal Biotech KRYS Stock Holding History

Wilmington Savings Fund Society’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146K	Hold	393	–	–	﹤0.01%	657
2026 Q1	$102K	Hold	393	–	–	﹤0.01%	732
2025 Q4	$96.9K	Hold	393	–	–	﹤0.01%	739
2025 Q3	$69.4K	Buy	393 +173	+79%	+$25.9K	﹤0.01%	824
2025 Q2	$30.2K	Sell	220 -5	-2%	-$734	﹤0.01%	1354
2025 Q1	$40.6K	Buy	225 +7	+3%	+$1.18K	﹤0.01%	1256
2024 Q4	$34.2K	Hold	218	–	–	﹤0.01%	1343
2024 Q3	$39.7K	Buy	+218	New	+$42K	﹤0.01%	1273

Other funds holding KRYS

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wilmington Savings Fund Society's KRYS Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Krystal Biotech (KRYS) position steady in Q2 2026 at 393 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Wilmington Savings Fund Society first reported a position in KRYS in Q3 2024 and has held it in 8 quarters since. 117 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Wilmington Savings Fund Society held 393 shares of Krystal Biotech worth $146K as of Q2 2026.
Wilmington Savings Fund Society left its Krystal Biotech share count unchanged in Q2 2026.
Krystal Biotech made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #657 holding.
Wilmington Savings Fund Society first reported a position in Krystal Biotech in Q3 2024 and has held it in 8 quarters since.
117 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.